U.S. Communications Stock News

Earlier in May 2026, FTI Consulting appointed Andreas P. Stöcklin to lead its Transactions practice across Continental Europe and named Emanuele Grasso as Senior Managing Director and head of the Corporate Finance segment in Italy, both joining the EMEA management structure to deepen M&A and transaction support capabilities. These hires bring decades of cross-border deal experience and board advisory expertise from firms such as Kroll and PwC, highlighting FTI Consulting’s intent to build...

In recent months, AngloGold Ashanti has faced increased scrutiny as ABSA Securities downgraded the miner, while insiders, including the CEO and a director, sold shares without any offsetting insider purchases. This combination of analyst caution on costs and operations alongside ongoing insider selling raises fresh questions about how management views the company’s current positioning. Now we’ll examine how ABSA’s downgrade, rooted in mining cost inflation and operational risk, may reshape...

Sun Communities (SUI) has drawn investor attention after recent share moves, with the stock up 1.2% over the past day and 5.1% over the past week, despite declines over the past month. See our latest analysis for Sun Communities. The recent 7 day share price return of 5.1% contrasts with more muted year to date gains of 4.6% and a 1 year total shareholder return of 10.2%. This suggests near term momentum is improving from a softer medium term trend. If this move in Sun Communities has you...

Illumina, Inc. has added former Labcorp Executive Chairman and CEO David P. King to its Board of Directors, following the May 21, 2026 annual shareholder meeting and alongside equity grants to several directors as part of their compensation. King’s deep background in large-scale diagnostics businesses and clinical operations underlines Illumina’s push to embed genomics more firmly into everyday medical decision-making as it refreshes its Board. We’ll now examine how King’s board appointment,...

Earlier in May 2026, BioMarin reported that its Phase 3 CANOPY-HCH-3 trial of VOXZOGO in children with hypochondroplasia met its primary endpoint, showing a statistically significant 2.33 cm/year gain in annualized growth velocity over placebo and meaningful improvements in arm span with a safety profile consistent with prior use in achondroplasia. Because hypochondroplasia currently has no approved therapies, these data and BioMarin’s plan to file a supplemental FDA application in the third...

How Balchem’s Recent Performance Frames the Story for Investors Balchem (BCPC) has been steady over the past day, but the stock is up about 1.4% over the past week and down roughly 7% over the past month, prompting closer investor attention. See our latest analysis for Balchem. That recent 7% one month share price pullback, alongside a 5.0% year to date share price gain and a 3 year total shareholder return of 34.3%, suggests momentum has cooled but long term holders have still been...

Recent share performance and context Oppenheimer Holdings (OPY) has seen mixed share performance recently, with the stock down about 3% over the past day and roughly 9% over the past month, yet up around 9% in the past 3 months. See our latest analysis for Oppenheimer Holdings. Despite the recent 9% decline in the 1 month share price return to US$93.86, momentum over the year still looks constructive. A 29.21% year to date share price return and a 50.07% 1 year total shareholder return...

In May 2026, MicroVision, Inc. reported first quarter 2026 results, with sales rising to US$935,000 from US$589,000 a year earlier, while net loss narrowed to US$25.29 million and basic loss per share improved to US$0.08 from US$0.12. This combination of higher sales and a smaller loss suggests incremental progress in MicroVision’s efforts to scale its lidar and perception technology business. We'll examine how this early revenue growth and reduced quarterly loss could influence...

Melco Resorts & Entertainment (MLCO) has been drawing attention after a period of weaker share performance, with the stock down over the past month and past 3 months. This has prompted closer scrutiny of its current valuation. See our latest analysis for Melco Resorts & Entertainment. At a latest share price of $5.38, Melco Resorts & Entertainment has seen its 7 day share price return fall 2.71% and its year to date share price return decline 28.36%, while the 5 year total shareholder return...

Why Post Holdings stock is on investors’ radar today Post Holdings (POST) is drawing attention after recent trading left the stock down over the past month and past 3 months, prompting investors to reassess its consumer packaged foods and foodservice footprint. At a recent close of US$97.17 and a market value of about US$4.4b, the company sits in the mid cap range for U.S. food and beverage stocks, with operations spanning cereals, pet food, refrigerated retail products, and foodservice...

Mirum Pharmaceuticals (MIRM) has just completed a zero coupon convertible note offering of $600 million due 2032, a financing move that can reshape its capital structure and influence how investors assess the stock. See our latest analysis for Mirum Pharmaceuticals. Mirum’s recent zero coupon convertible note offering comes after a mixed stretch for the stock, with the share price up 26.32% year to date but down 8.24% over 90 days. The one year total shareholder return of 124.14% and five...

Builders FirstSource previously filed a US$41.62 million shelf registration for 6,050,000 common shares tied to its ESOP and confirmed a planned leadership transition naming Mike Hiller as Chief Operating Officer-designate while appointing Coley O’Brien as Chief Human Resources Officer. This combination of an employee-focused share offering and a long-term succession plan underscores the company’s emphasis on workforce alignment and operational continuity. We’ll now examine how the COO...

Hub Group (HUBG) recently received a Nasdaq notice of non compliance after missing the filing deadline for its March 31, 2026 Form 10 Q, highlighting ongoing restatements and extended reporting uncertainty. See our latest analysis for Hub Group. The Nasdaq notice comes after Hub Group signaled delayed filings earlier in May, yet the stock has held relatively firm, with a 1-day share price return of 1.92%, a 7-day share price return of 8.62%, and a 1-year total shareholder return of 26.17%...

Event overview and recent share performance Open Text (NasdaqGS:OTEX) has drawn fresh attention after a period in which the stock is down about 26% year to date and down about 38% over the past 3 years, prompting investors to reassess the business. See our latest analysis for Open Text. Recent price action has been choppy, with a 1 month share price return of 4.73%, a year to date share price return that is down 26.06%, and a 3 year total shareholder return that is down 37.97%, signaling that...

Earlier this month, Driftwood Hospitality Management expanded its use of Flywire’s hospitality payments platform across nearly 90 U.S. hotel properties, digitizing contracts, deposits and multi-channel guest payments while cutting manual processing and fees, particularly through greater ACH adoption. This rollout shows how Flywire’s software-led payments model can reshape operational workflows for large hotel portfolios, pairing cost savings with a more seamless guest experience across major...

In May 2026, Inhibrx Biosciences reported a first-quarter net loss of US$33.44 million, narrower than a year earlier, and released positive interim Phase 2 data from its HexAgon trial of INBRX-106 plus pembrolizumab in first-line PD-L1 positive metastatic or unresectable recurrent head and neck squamous cell carcinoma. The interim data showed a higher confirmed objective response rate and the emergence of complete responses with the INBRX-106 combination, underscoring the potential...

Science Applications International (SAIC) has drawn fresh attention after its recent share performance, with the stock near US$100 and returns over the past 3 months outpacing its move over the past month. See our latest analysis for Science Applications International. At around US$100, the recent 3.99% 1 day and 14.19% 3 month share price returns suggest momentum has picked up again, even as the year to date share price return is slightly down and the 1 year total shareholder return has...

Recent stock move puts Old National Bancorp in focus Old National Bancorp (ONB) is back on investors’ radar after a recent share price move, with the stock last closing at US$23.94 and posting mixed short term returns across the past week and month. See our latest analysis for Old National Bancorp. That recent share price move sits within a steady trend, with a 1-year total shareholder return of 19.13% and a 3-year total shareholder return above 2x, suggesting momentum has been building over...

What Invitation Homes Stock Investors Are Watching Now Invitation Homes (INVH) has drawn attention after recent trading, with the stock last closing at $29.29. Investors are weighing this price against the company’s cash flow profile and recent share performance. See our latest analysis for Invitation Homes. Recent trading has added to a steady short term upswing, with a 30 day share price return of 7.96% and a 90 day share price return of 14.10%. However, the 1 year total shareholder return...

Meta Platforms stock performance snapshot Meta Platforms (META) has seen mixed share performance recently, with the stock up about 0.5% over the past day, slightly lower over the past week, and down over the past month and past 3 months. See our latest analysis for Meta Platforms. With the share price at US$610.26, Meta Platforms has recently pulled back, with the 30 day share price return down 9.6% and the year to date share price return down 6.2%. However, the 3 year total shareholder...

Insmed (INSM) is back in focus after recent trading pulled the stock down about 21% over the past month and roughly 33% over the past 3 months, prompting fresh attention on its rare disease portfolio. See our latest analysis for Insmed. At a share price of US$106.24, Insmed has seen short term momentum fade, with the 30 day share price return down 21.4% and the year to date share price return down 40%, even though the 1 year total shareholder return is 57.3% and the 3 year total shareholder...

Why CVS Health is on investors’ radar now CVS Health (CVS) is drawing fresh attention after its stock moved around current levels near US$93, with returns over the past month and past 3 months contrasting with a weaker recent week. See our latest analysis for CVS Health. At a share price of US$93.26, CVS Health has seen its short term share price momentum cool in the past week, even after strong 1 month and year to date share price returns and solid multi year total shareholder returns. If...

Walmart Inc. ( NASDAQ:WMT ) shareholders are probably feeling a little disappointed, since its shares fell 9.8% to...

It looks like CSX Corporation ( NASDAQ:CSX ) is about to go ex-dividend in the next three days. The ex-dividend date is...